MiSight® contact lenses are indicated for the correction of ametropia (myopia) and slowing the worsening of myopia.
These one-day contact lenses are specifically designed for children and easy to use and wear.†1-4 They feature ActivControl® Technology which cuts the worsening of myopia by approximately half and works for almost all children with myopia.‡¶3,5,6
For the device safety, warnings, precautions, and local regulatory information, please refer to the Instruction for Use leaflet
† Based on adherence to replacement schedule, lens handling, comfort, satisfaction, vision quality, and visual acuity findings.
‡ Using measured and modelled data, pooled across ages (8-17), myopia progression was slowed by an average of approximately 50% with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day
¶ 90% of myopic eyes respond to treatment with MiSight® 1 day (ages 11-15 at start of wear, n=90), which shares the same ActivControl® Technology with MyDay® MiSight® 1 day
References
1. CVI data on file 2025. Prospective, 1-week, double masked, randomised, bilateral crossover study with MiSight 1 day and MyDay MiSight 1 day. N=32 subjects aged 8-18 years.
2.Chamberlain P et al A 3-year Randomised Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
3.Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicentre Clinical Trial. OVS 2022 Mar 1;99(3):204-212.]
4.Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7 year findings. OVS 2021;98:E-abstract 210049.]
5. Arumugam B et al. Modelling Age Effects of Myopia Progression for the MiSight 1 day Clinical Trial. IOVS 2021;62(8):2333.
SA15980_1a CVY03261759-1
